BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03653507-completion@plaintrial.com
DTSTAMP:20261110T213915Z
DTSTART;VALUE=DATE:20260930
SUMMARY:A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo 
 Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-po
 sitive\, HER2-negative\, Locally Advanced Unresectable or Metastatic Gastr
 ic or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW). — estimated
  completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT03653507
URL:https://plaintrial.com/trial/NCT03653507
END:VEVENT
END:VCALENDAR